Clinical, biological and cytometric characteristics of two patients with a homozygous A91V PRF1 mutation
Clinical & Translational Immunology · 2026-03 · 15 (3)
DOI: 10.1002/cti2.70081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Translational Immunology, online erschienen am 15.03.2026. Verfasst von Nicolas Perrard und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Clinical Immunology CHU Lille Lille France. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Inborn errors of immunity are rare genetic disorders that cause dysfunction of the immune system. Among these, familial haemophagocytic lymphohistiocytosis (FHL) involves defects in the perforin/granzyme pathway, which is essential for regulating immune responses. These conditions predispose individuals to haemophagocytic lymphohistiocytosis, a life‐threatening hyperinflammatory syndrome. FHL has traditionally been described in paediatric patients with a fatal outcome in the absence of early haematopoietic stem cell transplantation. However, some patients harbouring missense mutations may present with atypical or late‐onset symptoms, for which management remains unstandardised. Among these reported variants, the pathogenicity of the A91V PRF1 mutation remains the most controversial in the literature.
Method
We report clinical, biological and cytometric characteristics of two patients with a homozygous PRF1 A91V mutation who developed clinical features consistent with FHL2.
Discussion
We discuss the latest 2024 classifications to better characterise this group of disorders and their underlying genetic basis, with particular emphasis on atypical presentations and the A91V mutation, which may pose diagnostic and therapeutic challenges.
Conclusion
A91V PRF1 variant appears to represent a risk factor for the development of atypical FHL manifestations under divers triggers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine and Clinical Immunology CHU Lille Lille France.
- Institute for Translational Research in Inflammation Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE Lille France.
- Regional Center for Primary Immune Deficiency CEREDIH, CHU Lille Lille France.
- Department of Neurology CRC-SEP, CHU Lille Lille France.
- LilNCog - Inserm U1172 Lille France.
- Department of Paediatric Haematology CHU Lille Lille France.
ORCID-Profile: Nicolas Perrard
Zitieren
APA
Perrard, N., Poggi, C., Sanges, S., Lemarchant, B., Chahlah, W. A., Terriou, L., Delangue, S., Trauet, J., Labalette, M., Hachulla, E., Moshous, D., Lefevre, G., & Launay, D. (2026). Clinical, biological and cytometric characteristics of two patients with a homozygous A91V PRF1 mutation. Clinical & Translational Immunology, 15(3). https://doi.org/10.1002/cti2.70081
Vancouver
Perrard N, Poggi C, Sanges S, Lemarchant B, Chahlah WA, Terriou L, et al. Clinical, biological and cytometric characteristics of two patients with a homozygous A91V PRF1 mutation. Clinical & Translational Immunology. 2026;15(3). doi:10.1002/cti2.70081
BibTeX
@article{Perrard2026,
author = {Perrard, Nicolas and Poggi, Claire and Sanges, Sébastien and Lemarchant, Bruno and Chahlah, Wadih Abou and Terriou, Louis and Delangue, Stéphanie and Trauet, Jacques and Labalette, Myriam and Hachulla, Eric and Moshous, Despina and Lefevre, Guillaume and Launay, David},
title = {Clinical, biological and cytometric characteristics of two patients with a homozygous A91V PRF1 mutation},
journal = {Clinical & Translational Immunology},
year = {2026},
volume = {15},
number = {3},
doi = {10.1002/cti2.70081}
}
EUVIMED